| 1978N-0065 | Skin Bleaching Drug Products | |||||||||||||||||||||||
| FDA Comment Number : | EC112 | |||||||||||||||||||||||
| Submitter : | Dr. Melissa Camouse | Date & Time: | 12/07/2006 11:12:02 | |||||||||||||||||||||
| Organization : | Dr. Melissa Camouse | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| As a physician it is a tragedy to see safe and efficacious medications that make a profound impact on patients' disease states become unavailable. Hydroquinone is one of the most effective agents for the treatment of skin discoloration over the past 40-50 years and has been used safely in millions of people. It is used to treat the daily concerns of our patients including melasma, photo-aging, post-inflammatory hyperpigmentation, medically and cosmetic disfiguring dyschromias.
Since 1961, hydroquinone has demonstrated a safe and effect profile among clinicians prescribing or recommending hydroquinone products. In spite of humans exposure to natural sources of hydroquinone in wheat, pears, berries, coffee, tea, onions, rice and red wine, there is not an association with carcinogenicity. There have been no reported cases of related malignancies in more than 50 years of use of HQ. | ||||||||||||||||||||||||